Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLOD2 | O00469 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | PLOD3 | O60568 | 2/20 | 0.40 |
| ▸ | PLOD1 | Q02809 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7779152 | 0.86 | PLOD2 (0.41) | PLOD2POLBAPEX1PLOD3PLOD1 | |
| SCHEMBL1924889 | 0.75 | PLOD2 (0.60) | PLOD2PLOD3PLOD1NPC1RAB9A | |
| SCHEMBL13758817 | 0.75 | TSHR (0.47) | POLBAPEX1HPGDPIK3CASMN1; SMN2 | |
| SCHEMBL13747926 | 0.75 | PIK3CA (0.40) | POLBAPEX1HPGDPIK3CAGAA | |
| SCHEMBL12159752 | 0.75 | PIK3CA (0.40) | POLBAPEX1HPGDPIK3CAGAA | |
| SCHEMBL1924321 | 0.75 | PLOD2 (0.59) | PLOD2POLBPLOD3PLOD1NPC1 | |
| SCHEMBL9818725 | 0.75 | PLOD2 (0.42) | PLOD2POLBPLOD3PLOD1HPGD | |
| SCHEMBL5117814 | 0.75 | PLOD2 (0.59) | PLOD2POLBPLOD3PLOD1HPGD | |
| SCHEMBL1924137 | 0.73 | ERCC5 (0.61) | PLOD2POLBPLOD3PLOD1HPGD | |
| SCHEMBL30680417 | 0.73 | ALDH1A1 (0.42) | POLBAPEX1HPGDGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080214642-A1 | Fungicidal N-Benzyl-5-Hydroxy-5-Phenylpryrazolines, Processes For Their Preparation and Compositions Comprising Them | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-04 | — | — | US | disclosed |
| EP-1893018-A1 | FUNGICIDAL N-BENZYL-5-HYDROXY-5-PHENYLPYRAZOLINES, METHODS FOR THE PRODUCTION THEREOF, AND AGENTS CONTAINING THE SAME | BASF SE (DE) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006128823-A1 | FUNGICIDAL N-BENZYL-5-HYDROXY-5-PHENYLPYRAZOLINES, METHODS FOR THE PRODUCTION THEREOF, AND AGENTS CONTAINING THE SAME | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-07 | — | — | WO | disclosed |
| US-6150303-A | Substituted 3-phenylisoxazolines | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-21 | — | — | US | disclosed |
| EP-0998468-A1 | SUBSTITUTED 3-PHENYL ISOXAZOLINES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-10 | — | — | EP | disclosed |
| WO-1999005130-A1 | SUBSTITUTED 3-PHENYL ISOXAZOLINES | BASF AKTIENGESELLSCHAFT (DE) | 1999-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214642-A1 | Fungicidal N-Benzyl-5-Hydroxy-5-Phenylpryrazolines, Processes For Their Preparation and Compositions Comprising Them | CBR3, CBR1, CYP4X1 | PLOD2 692/4885POLB 4014/4885APEX1 1912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.